S&P 500   3,293.21 (-0.04%)
DOW   26,635.84 (-0.11%)
QQQ   269.95 (+0.21%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.56 (+0.49%)
CGC   18.80 (-1.36%)
BABA   260.00 (+0.80%)
TSLA   1,523.00 (+2.56%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.29 (-1.25%)
GILD   71.35 (-0.53%)
NFLX   506.55 (+1.59%)
DIS   116.53 (+0.15%)
BAC   24.99 (-0.08%)
S&P 500   3,293.21 (-0.04%)
DOW   26,635.84 (-0.11%)
QQQ   269.95 (+0.21%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.56 (+0.49%)
CGC   18.80 (-1.36%)
BABA   260.00 (+0.80%)
TSLA   1,523.00 (+2.56%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.29 (-1.25%)
GILD   71.35 (-0.53%)
NFLX   506.55 (+1.59%)
DIS   116.53 (+0.15%)
BAC   24.99 (-0.08%)
S&P 500   3,293.21 (-0.04%)
DOW   26,635.84 (-0.11%)
QQQ   269.95 (+0.21%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.56 (+0.49%)
CGC   18.80 (-1.36%)
BABA   260.00 (+0.80%)
TSLA   1,523.00 (+2.56%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.29 (-1.25%)
GILD   71.35 (-0.53%)
NFLX   506.55 (+1.59%)
DIS   116.53 (+0.15%)
BAC   24.99 (-0.08%)
S&P 500   3,293.21 (-0.04%)
DOW   26,635.84 (-0.11%)
QQQ   269.95 (+0.21%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.56 (+0.49%)
CGC   18.80 (-1.36%)
BABA   260.00 (+0.80%)
TSLA   1,523.00 (+2.56%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.29 (-1.25%)
GILD   71.35 (-0.53%)
NFLX   506.55 (+1.59%)
DIS   116.53 (+0.15%)
BAC   24.99 (-0.08%)
Log in

NYSE:USPHU.S. Physical Therapy Stock Price, Forecast & News

$82.66
-0.40 (-0.48 %)
(As of 08/4/2020 09:43 AM ET)
Add
Compare
Today's Range
$82.00
Now: $82.66
$83.53
50-Day Range
$73.67
MA: $79.29
$84.38
52-Week Range
$45.13
Now: $82.66
$148.48
Volume64,807 shs
Average Volume67,354 shs
Market Capitalization$1.06 billion
P/E Ratio36.58
Dividend Yield1.54%
Beta1.27
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Read More
U.S. Physical Therapy logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.70 out of 5 stars


Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$481.97 million
Cash Flow$3.59 per share
Book Value$18.92 per share

Profitability

Net Income$40.04 million

Miscellaneous

Employees5,400
Market Cap$1.06 billion
Next Earnings Date8/6/2020 (Confirmed)
OptionableOptionable
$82.66
-0.40 (-0.48 %)
(As of 08/4/2020 09:43 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

How has U.S. Physical Therapy's stock been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, USPH shares have decreased by 11.3% and is now trading at $82.66.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of U.S. Physical Therapy?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for U.S. Physical Therapy
.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for U.S. Physical Therapy
.

How can I listen to U.S. Physical Therapy's earnings call?

U.S. Physical Therapy will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, May, 21st. The company reported $0.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by $0.07. The company earned $112.70 million during the quarter, compared to analyst estimates of $101.89 million. U.S. Physical Therapy had a net margin of 6.17% and a return on equity of 13.48%. U.S. Physical Therapy's revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 earnings per share.
View U.S. Physical Therapy's earnings history
.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Friday, February 28th. Investors of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 1.55%. The ex-dividend date is Thursday, March 12th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.30.
View U.S. Physical Therapy's dividend history
.

What price target have analysts set for USPH?

3 brokers have issued 12 month price objectives for U.S. Physical Therapy's shares. Their forecasts range from $80.00 to $95.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $87.50 in the next year. This suggests a possible upside of 5.9% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy
.

Has U.S. Physical Therapy been receiving favorable news coverage?

Media headlines about USPH stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. U.S. Physical Therapy earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.
View the latest news about U.S. Physical Therapy
.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,060,000 shares, a drop of 7.0% from the June 15th total of 1,140,000 shares. Based on an average trading volume of 162,600 shares, the days-to-cover ratio is currently 6.5 days. Approximately 8.4% of the company's shares are short sold.
View U.S. Physical Therapy's Current Options Chain
.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Marathon Petroleum (MPC), Royal Caribbean Cruises (RCL), Starbucks (SBUX), AbbVie (ABBV), Carnival (CCL), Gilead Sciences (GILD), IBM (IBM), Lowe's Companies (LOW) and AT&T (T).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.81%), Boston Trust Walden Corp (2.39%), Granite Investment Partners LLC (1.63%), Peregrine Capital Management LLC (1.26%), Copeland Capital Management LLC (1.10%) and Fenimore Asset Management Inc. (0.51%). Company insiders that own U.S. Physical Therapy stock include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy
.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, SG Americas Securities LLC, Envestnet Asset Management Inc., Riverbridge Partners LLC, Bridge City Capital LLC, and Hancock Whitney Corp. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was purchased by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Boston Trust Walden Corp, Peregrine Capital Management LLC, Fenimore Asset Management Inc., Chatham Capital Group Inc., Conestoga Capital Advisors LLC, UBS Group AG, and Aptus Capital Advisors LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $82.66.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.06 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.